🇺🇸 FDA
Patent

US 7732615

N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms

granted A61PA61P1/14A61P21/00

Quick answer

US patent 7732615 (N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms) held by ACADIA Pharmaceuticals Inc. expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P1/14, A61P21/00, A61P25/00, A61P25/06